In today’s episode, we spoke to Michelle Baker-Jones, one of the lead guides on the current Imperial College Randomised Control Trial (Psilodep 2) which is comparing the efficacy of Psilocybin with Anti-Depressants for the treatment of depressive disorder. Michelle is personable, thoughtful, and - as an integrative psychotherapist - seem to have good scope for how psychedelics can be best contextualised within the overall treatment regimen for clients suffering from depression.
